BPA decision soon, says FDA
The US Food and Drug Administration (FDA) said it would issue its overdue decision of the safety of bisphenol A (BPA) soon but refused to set a date or say why it failed to meet its own deadline for publication.
The US Food and Drug Administration (FDA) said it would issue its overdue decision of the safety of bisphenol A (BPA) soon but refused to set a date or say why it failed to meet its own deadline for publication.
Increased intake of coffee may reduce the risk of lethal and advanced prostate cancers by 60 per cent, according to new findings from the US.